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Symposium: 
Clinical Trials and Access to Essential 
Medicines in African Countries 
Access to Essential Medicines in African 
Countries: An Introduction 
PETER G. DANCHIN† AND DIANE HOFFMANN††  
The concept of a human right to health was first recognized inter-
nationally by the World Health Organization in 1946 when it declared 
that “the enjoyment of the highest attainable standard of health is one 
of the fundamental rights of every human being without distinction of 
race, religion, political belief, economic or social condition.”1  Since 
that time, the right has become encoded and entrenched in both con-
ventional and customary international law. 
Article 25 of the Universal Declaration of Human Rights (1948) 
recognizes the right to health as part of an adequate standard of living 
closely linked with other economic and social rights such as “food, 
clothing, housing and medical care and necessary social services.”2  
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 1. Economic and Social Council, Constitution Adopted by the United States of America 
and Other Governments respecting a World Health Organization 62 Stat. 2679, 14 U.N.T.S. 
185 (June 21, 1948) (establishing the World Health Organization, originally signed 22 July 
1946).  
 2. Universal Declaration of Human Rights, G.A. Res. 217 A (III), U.N. GAOR, 3d Sess., 
DANCHINHOFFMANNINTROFINALBOOKPROOF (DO NOT DELETE) 2/22/2017  1:40 PM 
2 MARYLAND JOURNAL OF INTERNATIONAL LAW [Vol. 31:1 
Today, the locus classicus of the right in international law is Article 12 
of the International Covenant on Economic, Social and Cultural Rights 
(1976) which provides that States Parties recognize “the right of eve-
ryone to the enjoyment of the highest attainable standard of physical 
and mental health” and that steps are to be taken in order to realize the 
right in the areas of (a) reduction of the still-birth rate and infant mor-
tality; (b) improvement of environmental and industrial hygiene; (c) 
prevention, treatment and control of diseases; and (d) creation of con-
ditions assuring to all medical service and attention in the event of 
sickness.3 Various other international and regional human rights instru-
ments have similar provisions.4  
It was within the context of tackling the global HIV/AIDS crisis 
in the 1990s that the first practical and theoretical linkages started to 
be made between the fields of health and human rights.  At a normative 
level, a key breakthrough occurred in 2000 when the UN Committee 
on Economic, Social and Cultural Rights issued General Comment 14 
on the right to health which had the effect of providing authoritative 
guidance on the scope and content of the right as well as ushering in a 
new era of work.  The focus of the General Comment is on the interre-
lated and essential elements of availability (sufficient quantity); acces-
sibility (physical, economic and non-discrimination); acceptability 
(being respectful of medical ethics and being culturally appropriate); 
and quality (scientifically and medically appropriate).  The committee 
further sought to give legal content to the obligations assumed by 
States (1) to respect (all persons and without interference to traditional 
care); (2) to protect (with legislative and other measures and include 
no restrictions to access); and (3) to fulfill (with positive measures in 
national, political, legal, and policy systems) the right to health.  
Since the early 2000s, numerous UN and regional human rights 
reports have explored how to operationalize the right to health accord-
ing to these criteria.  This has required translating legal standards into 
the design and functioning of entire health systems so as to ensure not 
 
1st plen. mtg., U.N. Doc. A/810 (Dec. 12, 1948), art. 25.  
 3. G.A. Res. 2200 (XXI) A, annex, International Covenant on Economic, Social and 
Cultural Rights, art. 12 (Dec. 16, 1966).  
 4. European Social Charter art. 11, opened for signature Oct. 18, 1961, E.T.S. No. 035 
(entered into force Feb. 26, 1965); Organization of American States [OAS] Res. XXX, Amer-
ican Declaration of the Rights and Duties of Man, art. 11 (May 2, 1948); Org. of African Unity 
[OAU], African Charter on Human and Peoples’ Rights art. 16, June 17, 1981, OAU Doc. 
CAB/LEG/67/3 rev. 5, 21 ILM. 58 (1982); G.A. Res. 44/25, Convention on the Rights of the 
Child, art. 23–4 (Nov. 20, 1989); G.A. Res. 34/180, Convention on the Elimination of Dis-
crimination Against Women, art. 12 (Dec. 18, 1979). 
DANCHINHOFFMANNINTROFINALBOOKPROOF (DO NOT DELETE) 2/22/2017  1:40 PM 
2016] SYMPOSIUM INTRODUCTION 3 
merely the identification of violations ex ante but the upfront promo-
tion and protection of the right.  The key elements in this normative 
development of the right can be traced through the reports of the suc-
cessive UN Special Rapporteurs on the right to health and, in particu-
lar, the widely regarded reports of Paul Hunt written between 2002–
2008.  Three elements, in particular, are discernable.   
First, a concern not only with outcomes (such as provision of es-
sential medicines and safe drinking water) but also with process (e.g., 
transparency, participation, and non-discrimination).  Second, the re-
alization that the health of individuals, communities and populations 
requires more than medical care but also a focus on the underlying de-
terminants of health such as access to safe water, adequate sanitation, 
an adequate supply of food and housing, healthy environmental condi-
tions, and health-related education.  And third, the proposition that the 
right gives rise to legally binding obligations on States, especially the 
obligation to ensure that its health system includes certain features and 
measures such as a comprehensive national plan and a minimum bas-
ket of health-related services and facilities.5  
The key question addressed in this Symposium6 is how exactly 
access to essential medicines is recognized and operationalized in both 
theory and practice as part of the human right to health, and what bar-
riers exist—historical, political, legal and socioeconomic—to the real-
ization of this right in the specific context of states in southern Africa.  
In particular, how might international legal regimes, in the areas of 
trade and intellectual property, pose obstacles to access to essential 
medicines in African countries.7 
The genesis of the Symposium lies in a remarkable collaboration 
that has developed between Chancellor College Faculty of Law in 
Zomba, Malawi and the University of Maryland Frances King Carey 
School of Law in Baltimore, Maryland, United States which began in 
2010 when the Global Health Interprofessional Council (GHIC) at the 
University of Maryland first sent a multidisciplinary team of faculty 
 
 5. For a comprehensive discussion of the right-to-health approach to strengthening 
health systems, see Gunilla Backman, Paul Hunt et al., Health Systems and the Right to Health: 
An Assessment of 194 Countries, 372 LANCET 2047 (2008).  
 6. The Symposium on Clinical Trials and Access to Essential Medicines in African 
Countries was held at the University of Maryland Frances King Carey School of Law on Oc-
tober 29–30, 2015.  
 7. Other topics addressed at the Symposium included the law and ethics of clinical trials 
and the obligations owed to host communities by clinical researchers and sponsors.  These 
papers are published in a parallel symposium issue of the Journal of Health Care Law and 
Policy, volume 19 (2016).  
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and students to Malawi to study the health and legal rights of orphans 
and vulnerable children.  Since then, successive visits of students and 
faculty have been made and, in 2013, the International & Comparative 
Law and Law & Health Care Programs at Maryland Law School 
teamed up to organize a series of lectures and a workshop at Chancellor 
College on the right to health and HIV/AIDS, as well as to discuss the 
HIV/AIDS legal clinics at the two schools.8 
The articles published following this Symposium reflect the 
unique and interdisciplinary nature of this collaboration.  The first ar-
ticle by Lucie White, Getting Real About Essential Medicines: “The 
Last Kilometer,”9 squarely addresses the question of what it means to 
realize the human right to essential medicines.  White begins with the 
hypothetical story of A, an eighteen-year-old girl in a West African 
nation, who develops a form of mental illness.  Her point is that the 
vantage point from which to evaluate the right to essential medicines 
must be “where the people who need the drug actually stand.”10  Real-
ization of the right, in other words, must be assessed from the perspec-
tive of the rights holders’ themselves, and this requires a systemic per-
spective on “the institutions and systems that failed to deliver the 
medicine that ‘last kilometer’ to the people who need them.”11   
White seeks to reframe the right to essential medicines as a “call 
for pragmatic action” that “addresses the treatment challenge from the 
bottom up and top down, so as to connect people with what they need 
to maintain wellbeing, even while sick, not through drugs alone, but 
through drugs within systems of care.”12  In doing so, she challenges 
four aspects of the contemporary debate.  First, the concept of essential 
medicines “since its origins has been constrained within a formalistic 
frame.”13 Second, the “dominant frame for understanding human rights 
has been similarly formalistic” and thus any hoped-for convergence 
between rights doctrine and access to essential medicine policy has 
 
 8. Further exchange visits were organized in 2015 in relation to the Access to Justice 
clinic at the Maryland Law School and spanned issues of criminal justice reform, effective 
assistance of counsel, and bail.  
 9.  Lucie White, Getting Real About Essential Medicines: “The Last Kilometer,”31 MD. 
J. INT’L L. 79 (2016). 
 10.  Id. at 81. 
 11. White here cites Paul Farmer’s notion of “structural violence” describing the social 
arrangements embedded in forms of political and economic organization that cause injury to 
people.  See Paul Farmer, Structural Violence and Clinical Medicine, 3 PLOS MED. 1686 
(2006).  
 12.  White, supra note 9, at 81. 
 13.  Id. at 87. 
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been undermined.14  Third, the movement for HIV/AIDS treatment, in 
effect, reframed the right to essential medicines from “a formalistic 
conception into a call for social movement and pragmatic action for 
change”15 (as reflected, for example, in the landmark decision of the 
South African Constitutional Court in Minister of Health v. TAC).16  
And finally, a “public health movement that embeds within it the right 
to essential medicines can transform the demand for ‘access to essen-
tial medicines’ into a call—and a movement—for holistic systems of 
care.”17 
The second article by Danwood Chirwa, Access to Medicines and 
Health Care in Sub-Saharan Africa: A Historical Perspective,18 dis-
cusses a vital and usually ignored dimension of the challenge of im-
proving access to essential medicines and medical care in African 
states: an historical account of the problem and the need to understand 
the “historical genesis and context” of these challenges.  Chirwa ad-
dresses five broad periods in his analysis of the nature of health care 
systems in Africa: first, the pre-colonial period and the ways in which 
approaches to health were “intricately linked to African communitar-
ian philosophy and beliefs”;19 second, the simultaneously “moderniz-
ing” and “marginalizing” impact of Christian missionaries during the 
period of colonialism in the late nineteenth century; third, the legal, 
political and economic changes effected by African nationalists in the 
post-independence period which both sought to extend medical ser-
vices to rural areas while leaving the colonial health system in place 
and ultimately resulted in “an uneasy relationship between traditional 
medicine and African customs and traditions, on the one hand, and 
western medicine and the received law, on the other”;20 fourth, the neg-
ative economic impact of the implementation by African governments 
of structural adjustment programs in the third and fourth decades fol-
lowing independence; and finally, the generally positive effects on 
health policy of the far-reaching democratization and constitutional re-
forms of the 1990s, especially regarding the acceptance of economic, 
social and cultural rights.   
The third article by Lisa Forman, The Inadequate Global Policy 
 
 14.  Id.  
 15.  Id.  
 16. (2002) (5) SA 721 (CC). 
 17.  White, supra note 9, at 87. 
 18.  Danwood Chirwa, Access to Medicines and Health Care in Sub-Saharan Africa: A 
Historical Perspective, 31 MD. J. INT’L L. 21 (2016). 
 19.  Id. at 23. 
 20.  Id. at 29. 
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Response to Trade-Related Intellectual Property Rights: Impact on Ac-
cess to Medicines in Low- and Middle-Income Countries,21 shifts focus 
to the question of how trade and intellectual property rules and regimes 
themselves may operate in international law to derogate the rights to 
health and life protected in international and regional human rights 
treaties.  Forman analyzes, in particular, the World Trade Organiza-
tion’s Agreement on Trade Related Aspects of Intellectual Property 
(TRIPS Agreement)22 and the increasing use by states of bilateral and 
free trade agreements (FTAs).  The inaccessibility of essential medi-
cines in low- and middle-income countries under the strictures of these 
regimes suggests that exiting global policy initiatives have failed and 
that “bolder measures” are needed if the drug gap is to be remediated.  
For Forman, this must take the form not merely of TRIPS flexibilities 
(which “turn the fundamental human right to health and affordable 
medicines into a rigidly restricted exception to a property right”)23 but 
actual suspension of the application of trade-related intellectual prop-
erty rights to essential drugs for affected countries in southern Africa.  
If this is to occur, the impetus must come from social actors and move-
ments.   
The final article by Chikosa Banda, Intellectual Property and Ac-
cess to Essential Pharmaceuticals: Recent Law and Policy Reforms in 
the Southern Africa Development Community Region,24 continues the 
focus on the 1994 TRIPS Agreement and the significant barriers this 
regime poses to access to essential medicines in developing countries.  
Banda explores in depth the various flexibilities, transition periods, 
waivers and exemptions potentially available to “least-developed 
countries” in terms of TRIPS compliance.  He suggests that these flex-
ibilities do offer countries in the southern African region “some policy 
space to facilitate the development of local production capacity” and 
that this can be “done through the creation of legal environments that 
permit the copying and imitation of technologies.”25   
Most discussions and reforms to date, however, have focused on 
 
 21.  Lisa Forman, The Inadequate Global Policy Response to Trade-Related Intellectual 
Property Rights: Impact on Access to Medicines in Low- and Middle-Income Countries, 31 
MD. J.INT’L L. 8 (2016). 
 22. Agreement on Trade-Related Aspects of Intellectual Property Rights, Apr. 15, 1994, 
Marrakesh Agreement Establishing the World Trade Organization, Annex 1C, 1869 U.N.T.S. 
299. 
 23.  Id. at 19. 
 24.  Chikosa Banda, Intellectual Property and Access to Essential Pharmaceuticals: Re-
cent Law and Policy Reforms in the Southern Africa Development Community Region, 31 MD. 
J. INT’L L. 44 (2016). 
 25.  Id. at 49. 
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facilitating the importation of essential medicines from countries such 
as India, rather than on spurring local and regional innovation and pro-
duction of pharmaceuticals.  Banda’s thesis is that importation of ge-
neric, essential medicines is at best a short- and medium-term solution 
and that countries in the region must move towards local production in 
order to achieve a sustainable long-term solution.  While the structural 
and fiscal challenges to pharmaceutical innovation and access are 
“multiple and multifaceted,” and while much “policy incoherence” re-
mains in and between national laws, countries in the region are “in-
creasingly becoming aware of the need to find sustainable solutions to 
the problem of how to access pharmaceutical products” and this reali-
zation is slowly leading to patent law reforms aimed at domesticating 
TRIPS flexibilities and harnessing of economies of scale in order to 
stimulate local and regional production.26  
These are vastly complex and difficult questions and, as the arti-
cles in the Symposium so vividly illustrate, the struggle to realize the 
right of access to essential medicines in African countries is, in many 
respects, just beginning.  Two strong themes, in particular, emerge: 
first, that much reigning neoliberal orthodoxy in the field of health and 
human rights needs urgently to be rethought and political space opened 
up to reconnect issues of poverty and human rights as matters of justice 
(not merely policy); and second, that gross violations of the right to 
health require us to look beyond immediate local and national contexts 
and to examine more critically the interconnected history, political 
economy and powerful transnational institutions that continue to shape 
the health-related laws and policies in post-colonial African states.   
 
 
 26.  Id. at 53–55, 73. 
